Generation of induced pluripotent stem cells from human renal proximal tubular cells with only two transcription factors, OCT4 and SOX2


  • Montserrat Nuria
  • Ramírez-Bajo María José
  • Xia Yun
  • Sancho-Martinez Ignacio
  • Moya-Rull Daniel
  • Miquel-Serra Laia
  • Yang Shenglian
  • Nivet Emmanuel
  • Cortina Carme
  • González Federico
  • Izpisua Belmonte Juan Carlos
  • Campistol Josep M.


  • Humans
  • Male
  • Induced Pluripotent Stem Cells
  • SOXB1 Transcription Factors
  • Cell Differentiation
  • Cells
  • Cultured
  • Octamer Transcription Factor-3
  • Cellular Reprogramming
  • Fluorescent Antibody Technique
  • Kidney Tubules
  • Proximal
  • Middle Aged

document type



The tubular epithelium of the kidney is susceptible to injury from a number of different causes, including inflammatory and immune disorders, oxidative stress, and nephrotoxins, among others. Primary renal epithelial cells remain one of the few tools for studying the biochemical and physiological characteristics of the renal tubular system. Nevertheless, differentiated primary cells are not suitable for recapitulation of disease properties that might arise during embryonic kidney formation and further maturation. Thus, cellular systems resembling kidney characteristics are in urgent need to model disease as well as to establish reliable drug-testing platforms. Induced pluripotent stem cells (iPSCs) bear the capacity to differentiate into every cell lineage comprising the adult organism. Thus, iPSCs bring the possibility for recapitulating embryonic development by directed differentiation into specific lineages. iPSC differentiation ultimately allows for both disease modeling in vitro and the production of cellular products with potential for regenerative medicine. Here, we describe the rapid, reproducible, and highly efficient generation of iPSCs derived from endogenous kidney tubular renal epithelial cells with only two transcriptional factors, OCT4 and SOX2. Kidney-derived iPSCs may provide a reliable cellular platform for the development of kidney differentiation protocols allowing drug discovery studies and the study of kidney pathology.

more information